AAAAAA

   
Results: 1-6 |
Results: 6
INCREMENTS IN BONE-MINERAL DENSITY OF THE LUMBAR SPINE AND HIP AND SUPPRESSION OF BONE TURNOVER ARE MAINTAINED AFTER DISCONTINUATION OF ALENDRONATE IN POSTMENOPAUSAL WOMEN
Authors: STOCK JL BELL NH CHESNUT CH ENSRUD KE GENANT HK HARRIS ST MCCLUNG MR SINGER FR YOOD RA PRYORTILLOTSON S WEI L SANTORA AC
Citation: Jl. Stock et al., INCREMENTS IN BONE-MINERAL DENSITY OF THE LUMBAR SPINE AND HIP AND SUPPRESSION OF BONE TURNOVER ARE MAINTAINED AFTER DISCONTINUATION OF ALENDRONATE IN POSTMENOPAUSAL WOMEN, The American journal of medicine, 103(4), 1997, pp. 291-297
ESOPHAGITIS ASSOCIATED WITH THE USE OF ALENDRONATE
Authors: DEGROEN PC LUBBE DF HIRSCH LJ DAIFOTIS A STEPHENSON W FREEDHOLM D PRYORTILLOTSON S SELEZNICK MJ PINKAS H WANG KK
Citation: Pc. Degroen et al., ESOPHAGITIS ASSOCIATED WITH THE USE OF ALENDRONATE, The New England journal of medicine, 335(14), 1996, pp. 1016-1021
EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: ADAMI S PASSERI M ORTOLANI S BROGGINI M CARRATELLI L CARUSO I GANDOLINI G GNESSI L LAURENZI M LOMBARDI A NORBIATO G PRYORTILLOTSON S REDA C ROMANINI L SUBRIZI D WEI L YATES AJ
Citation: S. Adami et al., EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 17(4), 1995, pp. 383-390
RESOLUTION OF ALENDRONATE EFFECTS ON BONE TURNOVER AND BMD AFTER MULTIYEAR TREATMENT OF OSTEOPOROTIC WOMEN
Authors: STOCK J BELL N CHESNUT C ENSRUD K GENANT H HARRIS S MCCLUNG M SINGER F YOOD R PRYORTILLOTSON S WEI L SANTORA A
Citation: J. Stock et al., RESOLUTION OF ALENDRONATE EFFECTS ON BONE TURNOVER AND BMD AFTER MULTIYEAR TREATMENT OF OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 10, 1995, pp. 197-197
ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING
Authors: CHESTNUT CH MCCLUNG MR ENSRUD KE BELL NH GENANT HK HARRIS ST SINGER FR STOCK JL YOOD RA DELMAS PD KHER U PRYORTILLOTSON S SANTORA AC
Citation: Ch. Chestnut et al., ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING, The American journal of medicine, 99(2), 1995, pp. 144-152
ORAL ALENDRONATE TREATMENT OF BONE LOSS IN POSTMENOPAUSAL OSTEOPENIC WOMEN
Authors: SANTORA AC BELL NH CHESNUT CH ENSRUD K GENANT HK GRIMM R HARRIS ST MCCLUNG MR SINGER FR STOCK JL YOOD RA DELMAS PD PRYORTILLOTSON S WEINBERG J
Citation: Ac. Santora et al., ORAL ALENDRONATE TREATMENT OF BONE LOSS IN POSTMENOPAUSAL OSTEOPENIC WOMEN, Journal of bone and mineral research, 8, 1993, pp. 190000131-190000131
Risultati: 1-6 |